Home › Funds › Simplify Asset Management Inc. › BNTC

Simplify Asset Management Inc. position in BNTC

BENITEC BIOPHARMA INC · Health Care

Simplify Asset Management Inc. reported holding 1,002,201 shares of BNTC (BENITEC BIOPHARMA INC) in its Q3 2026 13F filing — a position valued at US$10.0M, representing 0.17% of its reported portfolio and ranking #27 among its reported holdings. Simplify Asset Management Inc. has disclosed BNTC holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)1.00M sh
Reported value held$10.02M
Portfolio Weight0.17%
First reportedQ2 2024
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Simplify Asset Management Inc.'s BNTC position evolved

Simplify Asset Management Inc. first disclosed a stake in BNTC in Q2 2024 at 51,216 shares (US$358K). The position peaked in Q2 2026 at 1,005,557 shares, worth US$13.5M. Across 10 filings, Simplify Asset Management Inc. increased the stake 6 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,002,201 shares valued at US$10.0M. Notable position changes include a 128% increase in Q3 2024 (shares rose 37% over the following quarter), a 92% increase in Q4 2025 (shares fell 21% over the following quarter), a 272% increase in Q1 2026 (shares rose 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 51.22K $358.00K New
Q3 2024 116.53K $1.07M Add
Q4 2024 76.34K $964.14K Reduce
Q1 2025 76.73K $998.32K Add
Q2 2025 69.17K $809.32K Reduce
Q3 2025 78.72K $1.10M Add
Q4 2025 151.16K $2.04M Add
Q1 2026 562.24K $5.99M Add
Q2 2026 1.01M $13.45M Add
Q3 2026 1.00M $10.02M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BNTC and 13F data

BNTC (BENITEC BIOPHARMA INC) is a Health Care company. 52 other funds we track also report a position in BNTC — the largest reported positions include MONTANOVA CAPITAL, LLC (US$154.5M), Nantahala Capital Management, LLC (US$19.9M), INFINITUM ASSET MANAGEMENT, LLC (US$12.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BNTC

All BNTC fund holders →

FAQ

How long has Simplify Asset Management Inc. held BNTC?

Simplify Asset Management Inc. has disclosed BNTC holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is Simplify Asset Management Inc.'s current position in BNTC?

As of Q3 2026, Simplify Asset Management Inc. holds 1.00M shares of BNTC (BENITEC BIOPHARMA INC), valued at $10.02M, representing 0.17% of its reported portfolio and ranking #27.

Has Simplify Asset Management Inc. been buying or selling BNTC?

In the latest 13F filing (Q3 2026), Simplify Asset Management Inc. held unchanged its position in BNTC. The position peaked in Q2 2026 at 1.01M shares.

Which other funds hold BNTC?

Other major institutional holders of BNTC include MONTANOVA CAPITAL, LLC, Nantahala Capital Management, LLC, INFINITUM ASSET MANAGEMENT, LLC, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.